Andersons pediatric cardiology 382
Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (60.74 KB, 3 trang )
porousarterialprostheses.Surgery.
1971;70(6):940–953.
77.CampbellCD,GoldfarbD,DettonDD,etal.
Expandedpolytetrafluoro-ethyleneasasmall
arterysubstitute.TransAmSocArtifIntern
Organs.1974;20A:86–90.
78.CampbellCD,GoldfarbD,RoeR.Asmall
arterialsubstitute:expandedmicroporous
polytetrafluoroethylene:patencyversusporosity.
AnnSurg.1975;182(2):138–143.
79.TomizawaY,TakanashiY,NoishikiY,etal.
Evaluationofsmallcalibervascularprostheses
implantedinsmallchildren:activated
angiogenesisandacceleratedcalcification.
ASAIOJ.1998;44(5):M496–M500.
80.HeiseM,SchmidmaierG,HusmannI,etal.
PEG-hirudin/iloprostcoatingofsmalldiameter
ePTFEgraftseffectivelypreventspseudointima
andintimalhyperplasiadevelopment.EurJVasc
EndovascSurg.2006;32(4):418–424.
81.LinPH,ChenC,BushRL,etal.Small-caliber
heparin-coatedePTFEgraftsreduceplatelet
depositionandneointimalhyperplasiaina
baboonmodel.JVascSurg.2004;39(6):1322–
1328.
82.CagiannosC,Abul-KhoudoudOR,DeRijkW,et
al.Rapamycin-coatedexpanded
polytetrafluoroethylenebypassgraftsexhibit
decreasedanastomoticneointimalhyperplasiain
aporcinemodel.JVascSurg.2005;42(5):980–
988.
83.WellsWJ,YuRJ,BatraAS,etal.Obstructionin
modifiedBlalockshunts:aquantitativeanalysis
withclinicalcorrelation.AnnThoracSurg.
2005;79(6):2072–2076.
84.LiJS,YowE,BereznyKY,etal.Clinical
outcomesofpalliativesurgeryincludinga
systemic-to-pulmonaryarteryshuntininfants
withcyanoticcongenitalheartdisease:does
aspirinmakeadifference?Circulation.
2007;116(3):293–297.
85.ShemeshD,GoldinI,HijaziJ,etal.A
prospectiverandomizedstudyofheparin-bonded
graft(Propaten)versusstandardgraftin
prostheticarteriovenousaccess.JVascSurg.
2015;62(1):115–122.
86.KazaAK,PigulaFA.AreBioprostheticValves
AppropriateforAorticValveReplacementin
YoungPatients?SeminThoracCardiovascSurg
PediatrCardSurgAnnu.2016;19(1):63–67.
87.AkinsCW.Resultswithmechanicalcardiac
valvularprostheses.AnnThoracSurg.
1995;60(6):1836–1844.
88.DangasGD,WeitzJI,GiustinoG,MakkarR,
MehranR.ProstheticHeartValveThrombosis.J
AmCollCardiol.2016;68(24):2670–2689.
89.LinSS,TiongIY,AsherCR,etal.Predictionof
thrombus-relatedmechanicalprostheticvalve
dysfunctionusingtransesophageal
echocardiography.AmJCardiol.
2000;86(10):1097–1101.
90.EdwinF,AniteyeE,TetteyMM,TamateyM,
Frimpong-BoatengK.Outcomeofleftheart
mechanicalvalvereplacementinWestAfrican
children–a15-yearretrospectivestudy.J
CardiothoracSurg.2011;6:57.
91.AlexiouC,McDonaldA,LangleySM,etal.
Aorticvalvereplacementinchildren:are
mechanicalprosthesesagoodoption?EurJ
CardiothoracSurg.2000;17(2):125–133.
92.ShanmugamG,MacArthurK,PollockJ.
Mechanicalaorticvalvereplacement:long-term
outcomesinchildren.JHeartValveDis.
2005;14(2):166–171.
93.AlexiouC,GalogavrouM,ChenQ,etal.Mitral
valvereplacementwithmechanicalprosthesesin
children:improvedoperativeriskandsurvival.
EurJCardiothoracSurg.2001;20(1):105–113.
94.SachwehJS,TieteAR,MuhlerEG,etal.
Mechanicalaorticandmitralvalvereplacement
ininfantsandchildren.ThoracCardiovascSurg.
